Search Results for 'Olaparib-Brca'

Olaparib-Brca published presentations and documents on DocSlides.

Please note, these are the actual video-recorded
Please note, these are the actual video-recorded
by blindnessinfluenced
proceedings from the live CME event and may includ...
Case Discussion: Second
Case Discussion: Second
by celsa-spraggs
Opinion. 55 year-old woman with . recurrent . ova...
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing
by alexa-scheidler
Phase I Study of Olaparib and Temozolomide, in pa...
 Patient Selection for PARP
Patient Selection for PARP
by sherrill-nordquist
Inhibitors:. Purpose and Practicalities . Present...
BRCA1 and BRCA2 Full Gene Sequence Analysis and Common DeletionDuplic
BRCA1 and BRCA2 Full Gene Sequence Analysis and Common DeletionDuplic
by beatrice
Testing includes full gene sequencing of exons and...
Lynch Syndrome and BRCA 1/2
Lynch Syndrome and BRCA 1/2
by yoshiko-marsland
21 yo female px to GP with 3/52 of severe abdomin...
by littleccas
actual. . video-recorded proceedings from the . l...
Year in Review Prostate Cancer
Year in Review Prostate Cancer
by faith
Emmanuel . S . Antonarakis. , MD. Professor of Onc...
by medshair
Five-year . survival. 15%. 30%. 40%. ?50%?. First ...
The Nurse View: Clinical Considerations in the Management of
The Nurse View: Clinical Considerations in the Management of
by natalia-silvester
BRCA. -Mutated Advanced Ovarian Cancer. Moderator...
NonBreast / NonOvarian BRCA1/2 related neoplasms: a growing entity
NonBreast / NonOvarian BRCA1/2 related neoplasms: a growing entity
by skylar
Laura Cortesi. BRCA1/2 Mutations: Cancer Risks. BR...
Why and how to test for germline
Why and how to test for germline
by isabella2
BRCA. mutations in Pancreatic Cancer. ESDO Learni...
Breast  Cancer Risk:  Genes
Breast Cancer Risk: Genes
by victoria
and the . Environment. Note: You will need to prov...
ACC ACC BLCA BLCA BRCA BRCA
ACC ACC BLCA BLCA BRCA BRCA
by hadly
CESC. CESC. CHOL. CHOL. COAD. COAD. DLCB. DLCB. ES...
Hereditary syndromes, genetic testing and
Hereditary syndromes, genetic testing and
by Kingslayer
gynaecological. cancers. Prof.. Nicoletta . Col...
CARCINOMA (BRCA) LEC 2 Dr.Eaman
CARCINOMA (BRCA) LEC 2 Dr.Eaman
by lily
. suud. . khalifa. Learning objectives:. Discuss ...
Results Generation of Pathogenic and Benign
Results Generation of Pathogenic and Benign
by madeline
BRCA2. Variants. by Site-Directed Mutagenesis. Me...
Clinical Cancer Genetics in
Clinical Cancer Genetics in
by luna
Breast and Ovarian Cancers. The Role of Cancer Gen...
DNA  damage repair; good or bad for
DNA damage repair; good or bad for
by ximena
. . cancer . development and treatment. Ka...
PackageXevaJune152021TypePackageTitleAnalysisofpatientderivedxenog
PackageXevaJune152021TypePackageTitleAnalysisofpatientderivedxenog
by delcy
2ABCAUC..............................................
TheXevaUsersGuideArvindMer12andBenjaminHaibeKains123451Princess
TheXevaUsersGuideArvindMer12andBenjaminHaibeKains123451Princess
by isla
TheXevaUser'sGuide1Introduction TheXevapackageprov...
Susceptibility
Susceptibility
by adhesivedisney
........................... ..... .. .............
 Breast cancer occurs when cells proliferate uncontrollably in breast tissue
Breast cancer occurs when cells proliferate uncontrollably in breast tissue
by olivia-moreira
BRCA2 is a tumor suppressor gene responsible for ...
 Measurement of Recurrence in Human TNBC cell Culture containing the BRCA1 Gene
Measurement of Recurrence in Human TNBC cell Culture containing the BRCA1 Gene
by myesha-ticknor
Preksha Jerajani. BNFO 300. Triple Negative Breas...
Dominance
Dominance
by yoshiko-marsland
. Inheritance. . Review. . Incomplete. . Inhe...
Genetic testing for breast cancer
Genetic testing for breast cancer
by faustina-dinatale
Susan M. Domchek, MD. Basser Professor of Oncolog...
56 th
56 th
by liane-varnes
Annual Ob-Gyn Update. Ovarian Cancer:. Finally. ...
DNA
DNA
by phoebe-click
damage repair; good or bad for . . . ca...
What Clinicians Want to Know:
What Clinicians Want to Know:
by violet
Understanding the Factors Affecting the Optimal Di...
GU CONNECT  PARP inhibitors in Prostate Cancer
GU CONNECT PARP inhibitors in Prostate Cancer
by jocelyn
Latest developments. . Prof.. . Neeraj Agarwal, ...
Genomic Prostate Cancer Testing for Olaparib
Genomic Prostate Cancer Testing for Olaparib
by abigail
Laura Yarram-Smith . Solid Tumour Lead SWGLH. J...
 Updates in Ovarian Cancer Care
Updates in Ovarian Cancer Care
by ellena-manuel
Lisa McCluskey, MD. Gynecologic Oncologist. June ...
 NEw developments IN  gynecological Oncology
NEw developments IN gynecological Oncology
by cheryl-pisano
highlights from the. EUROPEAN . society . of med...
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing
by karlyn-bohler
Phase I Study of Olaparib and Temozolomide, in pa...
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
by conchita-marotz
PARP Inhibitors: What Do We know?. PARP Inhibitor...
PARP Inhibitors and Cancer:    What Do You Need to Know?
PARP Inhibitors and Cancer: What Do You Need to Know?
by pasty-toler
This program will include a discussion of off-lab...
Updates in Ovarian Cancer Care
Updates in Ovarian Cancer Care
by tatiana-dople
Lisa McCluskey, MD. Gynecologic Oncologist. June ...
Ovarian cancer update  Kentucky cancer  Registry
Ovarian cancer update Kentucky cancer Registry
by danika-pritchard
9/8/2016 . Erica . Takimoto. , D.O., F.A.C.O.O.G....